Damaris Y. Hernandez

FDA investigator · also recorded as Ors Lee Damaris Hernandez

Appears on 17 documents from 2022 to 2026, mostly at sites in Florida. Most often cites responsibilities of quality control unit (21 CFR 211.22).

17
Documents on file
5.1
Observations per 483
2022
First seen
2026
Most recent

What they cite most

From 83 observations

Activity by year

2022: 5, 2023: 3, 2024: 2, 2025: 5, 2026: 2

Where

Florida 9 · Texas 2 · Brazil 1 · India 1 · Kansas 1 · New Jersey 1

Is Damaris Y. Hernandez coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

17 documents, newest first
FirmOpen
483 Bausch and Lomb IncorporatedMar 20, 2026 · Tampa, Florida
483 Catalent Pharma Solutions, LLCJan 30, 2026 · Saint Petersburg, Florida
483 Immacule Lifesciences Private LimitedSep 18, 2025 · Solan, India
483 Glenmark Pharmaceuticals Inc.Jun 17, 2025 · Monroe, North Carolina
483 Geri-Care Pharmaceuticals, CorpMay 5, 2025 · Lakewood, New Jersey
483 Pharmco Laboratories Inc.Mar 20, 2025 · Titusville, Florida
Amended 483 Pharmco Laboratories Inc.Mar 20, 2025 · Titusville, Florida

About this profile

What does Damaris Y. Hernandez inspect?

Damaris Y. Hernandez appears on 17 documents on file covering 16 sites, mostly in Florida.

What do they cite most often?

21 CFR 211.22 (responsibilities of quality control unit), followed by 21 CFR 211.113 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Damaris Y. Hernandez is dated Mar 20, 2026.